Critsal B 100 Inhaler: Your Premier PCD Pharma Franchise in Pulmonology

About Levosalbutamol + Beclometasone: A Dual-Action Therapy for Respiratory Control

Tapping into the High-Demand Market of Chronic Respiratory Disorders

Why Critsal B 100 Inhaler is a High-Profit Opportunity for Distributors

Partnering for Success with a Quality-Assured Product
Join Our Pharma Franchise for Unmatched Business Support

Home/Products /levosalbutamol-sulphate-100-mcg-beclometasone-100-mcg-inhaler

About the Product

Description


Critsal B 100 Inhaler is a highly effective combination medication that provides a powerful dual-action approach to the long-term management of chronic respiratory diseases. It contains a precise dose of Levosalbutamol Sulphate (100 mcg), a fast-acting bronchodilator, and Beclometasone (100 mcg), a potent inhaled corticosteroid. This strategic combination works synergistically to address both the immediate symptoms of bronchospasm and the underlying airway inflammation, offering a comprehensive and sustained level of control that significantly improves breathing, reduces the frequency of attacks, and enhances the overall quality of life for patients.

The respiratory segment of the Indian pharmaceutical market is a high-volume, high-value sector with a consistently high demand. The rising prevalence of respiratory disorders, fueled by factors such as increasing air pollution, smoking, and an aging population, ensures a continuous and robust need for advanced maintenance therapies. Products like Critsal B 100 Inhaler are a staple in the pulmonology and general medicine segments, with a stable prescription base from a wide range of healthcare professionals. This makes it a strategic choice for any distributor seeking a stable and profitable business, as its essential nature guarantees a steady and predictable revenue stream.

We are dedicated to empowering our franchise partners with all the tools necessary for success. Our product, manufactured in a WHO-GMP certified facility, ensures impeccable quality, efficacy, and safety, which is crucial for building trust with healthcare professionals and patients. We provide a complete promotional and marketing kit, including visual aids and product literature, to support your sales efforts. Our robust supply chain guarantees timely delivery and continuous stock availability, preventing any business interruptions. Partner with us to enter this stable and highly profitable market and establish a reputable and successful business as a key supplier of this top-quality respiratory medicine.

May include hoarseness, throat irritation, dry mouth, or cough. Long-term use can rarely lead to oral thrush (fungal infection). Rinse mouth after each use to prevent this.

Persistent asthma (mild to severe) Chronic obstructive pulmonary disease (COPD) Allergic and non-allergic airway inflammation Nebulization therapy in children and adults as prescribed

Use only with a nebulizer under medical supervision. Not for acute asthma attacks – use a rescue inhaler for quick relief. Rinse mouth after inhalation to prevent infections. Regular use is important for effectiveness – do not skip doses. Do not stop suddenly without consulting your doctor.

Store below 25°C. Protect from light and moisture. Do not freeze. Keep out of reach of children. Use immediately after opening the respule.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Frequently Asked Questions

What are the business opportunities for Levosalbutamol Sulphate 100 mcg + Beclometasone 100 mcg Inhaler in the PCD pharma franchise market?

This inhaler is used for asthma, COPD, bronchospasm, and chronic airway inflammation. Levosalbutamol provides quick bronchodilation, while beclometasone controls inflammation, making it a strong respiratory inhalation therapy product for medical distributors, wholesalers, and pharma franchise partners in the PCD pharma pharma franchise market.

Why should medical distributors include this inhaler in their range?

Medical distributors and wholesalers can benefit from steady demand in pulmonology clinics, hospitals, and respiratory specialty care. It is widely prescribed for long-term asthma and COPD control, ensuring repeat prescriptions and consistent chronic-care sales.

Does Cafoli Lifecare offer PCD pharma franchise opportunities for this product?

Yes, Cafoli Lifecare offers PCD pharma pharma franchise opportunities for respiratory inhalation formulations with monopoly rights, quality manufacturing standards, competitive pricing, and reliable supply support for distributors and medical agencies.

What benefits do wholesalers get by partnering for this inhaler?

Wholesalers and medical agencies benefit from specialist prescriptions, hospital procurement, chronic respiratory disease management, and steady repeat usage when partnering with Cafoli Lifecare.

How can I become a distributor or franchise partner for this inhaler?

Medical distributors, stockists, wholesalers, and pharma professionals interested in this inhalation formulation can contact Cafoli Lifecare to discuss PCD pharma franchise opportunities, pricing, product availability, and distribution support services.